{"id":"W2169039067","doi":"10.1158/1078-0432.ccr-13-2293","title":"Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Erlotinib; Vandetanib; Gemcitabine; Gefitinib; Cytotoxicity; Pharmacology; Cabozantinib; Medicine; Nucleoside; Cancer research; Cancer; Chemistry; Internal medicine; In vitro; Epidermal growth factor receptor; Hepatocellular carcinoma; Sorafenib; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008367639,0.0002036007,0.0003290539,0.00005163943,0.0002407066,0.00008562877,0.0002177018,0.0002903966,0.0007626803],"category_scores_gemma":[0.00007735738,0.0001762026,0.00009119132,0.0001228933,0.0005453858,0.00001474616,0.0001852291,0.0005980844,0.00001083161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001969012,"about_ca_system_score_gemma":0.0001303822,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006097815,"about_ca_topic_score_gemma":0.0006522296,"domain_scores_codex":[0.9976566,0.0002617298,0.0005022339,0.0007660019,0.0003104001,0.0005029935],"domain_scores_gemma":[0.9988806,0.0001602857,0.00008793346,0.0003216318,0.0002160611,0.0003334483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000246107,0.0001151566,0.05884409,0.00007041792,0.000151717,0.00001316127,0.0001144033,0.000009457647,0.921831,0.00001460958,0.0120436,0.006546351],"study_design_scores_gemma":[0.005917206,0.001830409,0.2571105,0.0003445618,0.0001222658,0.000006898409,0.0003658953,0.0002523955,0.7097104,0.001196746,0.02211956,0.001023212],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923591,0.00539072,0.00005061549,0.0009717461,0.00008466433,0.0007869223,0.0001000253,0.00001747856,0.000238729],"genre_scores_gemma":[0.9944184,0.002949108,0.0001723674,0.0004675668,0.0009767659,0.0003453974,0.00003777872,0.00004172584,0.0005908667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2121206,"threshold_uncertainty_score":0.9218112,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1048941416274085,"score_gpt":0.4375857204330001,"score_spread":0.3326915788055916,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}